308 related articles for article (PubMed ID: 17690183)
1. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
[TBL] [Abstract][Full Text] [Related]
2. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
4. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
[TBL] [Abstract][Full Text] [Related]
5. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.
Bian F; Nath R; Sobocinski G; Booher RN; Lipinski WJ; Callahan MJ; Pack A; Wang KK; Walker LC
J Comp Neurol; 2002 May; 446(3):257-66. PubMed ID: 11932941
[TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
8. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
[TBL] [Abstract][Full Text] [Related]
10. Tau and axonopathy in neurodegenerative disorders.
Higuchi M; Lee VM; Trojanowski JQ
Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
[TBL] [Abstract][Full Text] [Related]
11. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
12. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
13. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ
J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784
[TBL] [Abstract][Full Text] [Related]
16. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model.
Marinković P; Blumenstock S; Goltstein PM; Korzhova V; Peters F; Knebl A; Herms J
Brain; 2019 Apr; 142(4):1051-1062. PubMed ID: 30847469
[TBL] [Abstract][Full Text] [Related]
18. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
[TBL] [Abstract][Full Text] [Related]
19. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1.
Boutajangout A; Leroy K; Touchet N; Authelet M; Blanchard V; Tremp G; Pradier L; Brion JP
Neurosci Lett; 2002 Jan; 318(1):29-33. PubMed ID: 11786218
[TBL] [Abstract][Full Text] [Related]
20. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
